Verified ProfileEN

Junshi Biopharmaceutical (Xiamen) Co., Ltd.

Order verification — $199

Manufacturing · Canned Food Manufacturing

Verification dossier

Junshi Biopharmaceutical (Xiamen) Co., Ltd. is a Chinese company based in Xiamen, Fujian. The company operates in the canned food manufacturing sector, within the broader manufacturing industry. Established 2013, the company has been operating for 13 years.

Sinolinks tracks Junshi Biopharmaceutical (Xiamen) Co., Ltd. as part of our independent verification practice. The full 18-section verification report covers ownership, financial standing, regulatory standing, trade relationships, and operating credentials — reviewed by our Hong Kong-based expert and delivered in 24 hours.

Business scope

General items: Medical research and experimental development. (Projects subject to approval according to law can be operated independently with a business license). Licensed items: Food production; beverage production; food sales; food internet sales; food internet sales (pre-packaged food sales); food sales (bulk food sales); food sales (pre-packaged food sales); food import and export; import and export of goods; import and export of technology. (Projects subject to approval according to law can be operated after approval by relevant departments, and specific business projects are subject to approval documents or licenses).

Independent verification

Order the full verified report on this company

An 18-section verification report on this Chinese company, expert-reviewed and delivered in English within 24 hours. We support clients in six languages. HK-entity invoicing.

Order verification — $199

Independent verification

Included in the full report

Full Chinese legal name

Registration identifier

Legal representative & senior officers

Beneficial ownership & equity history

Registered address & operating premises

Capital & recent annual filings

Verified contact channels

Branches, controlled entities & investments

Trademark & patent portfolio

Trade relationships

Regulatory standing review